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Abstract 
Background: To study the surgical management 
outcome of Hidradenitis suppurativa  
Methods: In this descriptive study, patients presenting 
with Hidradenitis suppurativa were analyzed  with 
reference to presentation and surgical management 
outcome. 
Results: Out of 31 patients  3 (09.67%) patients were 
male and 28 (90.32%) were female. Mean duration of onset 
of disease and presentation was 15 months.  Axilla was the 
 commonest  site involved(74.19%) followed by 
inframammary fold (19.35%). Nine (29.03%) patients 
presented in the emergency in the form of single or 
multiple abscess requiring incision & drainage. Excision 
and primary skin grafting was the most frequent surgical 
procedure performed in 54.83% with acceptable outcome. 
Conclusion: Hidradenitis suppurativa needs  
individualized patient based management strategy with 
close collaboration of surgeon and dermatologist. 
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Introduction 
      Hidradenitis suppurativa (HS) is a chronic 
recurrent inflammatory process involving apocrine 
sweat glands and adjacent connective tissue. For many 
years this  condition was described as Verneuil’s 
disease, but subsequently became known as 
Hidradenitis suppurativa. Its association with acne 
was found . An experimental model of the disease in 
which zones of apocrine glands of normal human 
volunteers were occluded using adhesive tapes, is also 
demonstrated .HS  is clinically characterized by 
recurrent, painful, deep-seated, rounded nodules and 
abscesses with subsequent hypertrophic scarring and 
suppuration of apocrine gland bearing skin. The 
disease tends to become chronic with subsequent 
extension leading to hypertrophic scarring, sinus, and 
fistula.1 The onset of disease is usually after puberty 
and it worsens mainly during the second and third 
decades. By order of frequency , the affected sites, are 
axillary, inguinal, inner thighs, perianal and perineal, 
mammary and inframammary, buttocks, pubic region, 
scrotum, vulva, chest, scalp, retro auricular and eyelid. 
Axilla groin and sub mammary region are most 
commonly affected in women; perianal, perineal skin 
tend to be more severe in males. Recurrence occurs in 
and around the original site. 1-3 
      Seriousness and course of disease are variable, but 
untreated HS is typically a relentless progressive 
disease with acute exacerbations and remissions 
leading  to dramatic clinical picture. The quality of life 
is severely impaired. 4,5   
 
Patients and Methods 
    This study was conducted at Women Medical 
Complex (WMC) Sialkot   during the period from 
January 2009 to December 2011. Diagnosis was made 
on clinical findings and the grading and staging of the 
disease was performed .  Patients with stage I   were 
put on combination of antibiotic including, 
metronidazole 400 mg tds, Tetracycline (Minocycline) 
100 mg BD, and Clindamycin 300 mg tds for 3 months. 
All the patients with stage II, III and those with failed 
conservative and or poor drug tolerance and 
compliance were subjected to different surgical 
procedures depending upon stage and extent of 
disease. All the patients received    combination 
antibiotic therapy at least for one month before 
surgical intervention except those who presented with 
an abscess in whom incision and drainage was 
performed followed by  antibiotics. . 
 
Results 
    A total of 31 patients with diagnosis of Hidradenitis 
suppurativa were enrolled during  the study period. 
There were  only three (09.67%) male patients, rest 
were female. Mean age was 31 years. Majority (83.87%) 
were obese with BMI in relation to their height and 
weight.  Mean time elapsed since start of disease and 
presentation  was 15 months. Seventeen (54.83%) 
patients took treatment from local doctors and/or 
homeopathic before presenting to surgeon. Seven 
(22.58%) were referred by dermatologists.   Nine  
(29.03) had tried traditional healers, etc.  Associated 
problems like acne were found in 35.48%. The 
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commonest site of body involvement was axilla 
(74.19%)(Table 1). Bilateral disease was seen in 
35.48%s.  Solitary or in the form of multiple resolving 
and impending abscess was  seen in 29.03% followed 
by chronic scarring and mixed features seen in 
22.58%(Table 2). 
      Excision and partial split thickness skin grafting 
was the most frequent surgical procedure performed 
(54.38%) . Incision and drainage was performed in 
29.03%. Out of these 9 patients eight  were subjected to 
surgical procedures either excision and skin grafting 
or excision and primary closure where possible after 
control of acute infection . Recurrence of disease was 
the most observed complication in different treatment 
groups(Table 3). 
 
Table 1: Site of involvement with 
Hidradenitis Suppurativa: 
Site of body No(%) 
Axilla  23(74.19) 
Breast ( inframammary fold) 06(19.35) 
Gluteal region 01(3.22) 
Perianal 01(3.22) 
Multiple sites 11(35.48) 
 
Table 2:  Presenting features of Hidradenitis 
Suppurativa 
Presenting feature No(%) 
Abscess 09(29.03) 
Sinuses 06(19.35) 
Cellulitis 02(6.45) 
Chronic scar 07(22.58) 
Mixed feature  07(22.58) 
 
Table 3:  Surgical procedures performed 
Procedure No(%) Recurrence 
Incision & Drainage 09(29.03)    (09) 100% 
Excision & Primary 
Skin Graft 
17(54.83)    (03) 9.67% 
Excision & Primary 
closure 
05(16.12)    (02) 40% 
 
Discussion 
   HS is a chronic skin condition involving the apocrine 
glandular zones of the body. It is an intractable 
condition. Affected patients may present with acute 
abscess, but the condition often progresses to a chronic 
state with persistent pain, sepsis, sinus tracts and 
fistula formation, purulent discharge and dermal 
scarring. Treatment of patients with complex disease 
can be difficult and may require a complex surgical 
intervention. 6,7 
       HS of the axillary region in its early stage is 
frequently managed by the dermatologist. Therapy 
may consist of antibiotics (usually anti staphylococcal 
medications for axillary disease and broad spectrum 
agents for perineal disease) and simple measures like 
frequent application of antibiotics and warm 
compresses. Management of chronic disease of 
whatever the site involved is difficult. Surgical 
intervention is required in such cases either in an 
emergency  like incision and drainage of an abscess or 
in the form of elective definitive procedures like 
excision and primary closure , excision and primary 
split thickness skin graft , excision and skin flap, and   
deroofing of sinuses. Controversy still exists regarding 
the optimal surgical approach in the management of 
Hidradenitis suppurativa. Factors influencing the 
decision include the site affected, the extent of the 
disease, acute or chronic nature at the time of 
presentation, and the bias of the surgeon treating the 
case.   Every surgical procedure may not be suitable 
for every patient with any site involved with HS. For 
example, excision and skin grafting is generally 
considered unsuitable in the management of 
inguinoperineal disease. In cases of axillary disease it 
is an excellent procedure with acceptable results. 8-10 
           The major determinant of surgical outcome in 
the management of HS is the extent of the skin 
excision. This single factor may influence recurrence 
rates than a particular method of wound management. 
Recurrence after surgery is likely if excision is 
inadequate or if there is unusual wide distribution of 
apocrine glands. Patients with axillary HS treated by 
local excision and primary suture may require a 
second operation.  Present  study also found high 
recurrence rate after excision and simple primary 
repair.  This implies that in those cases where primary 
skin closure was being performed there was a degree 
of compromise in the extent of the excision margin 
leading to an increased incidence of recurrence. 
Adequate excision of the apocrine gland bearing skin 
area is the single most important determinant of 
surgical outcome of any procedure performed in the 
management of HS. In most instances recurrent 
disease is managed adequately by wide local excision 
of the affected area, allowing the wound to heal by 
secondary intention.11-15 
 
Conclusions 
1.Treatment of HS is difficult and complex with 
variable outcome depending upon the site involved 
and extent of disease. 
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2. Acceptable outcome can only be achieved by 
applying tailored made dermo-surgical approach with 
a coordination of surgeon and dermatologist.  
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